Orthofix Medical Inc. announced that Catherine Burzik has been re-appointed as the Chair of the Company’s Board of Directors. Additionally, shareholders re-elected Wayne Burris who previously served on the Orthofix board from 2021-2022. Burris will serve on the Audit and Finance and Compliance and Ethics Committees.

As previously announced Jon Serbousek, who served as Executive Chairman of the Board, did not stand for re-election at the annual shareholders meeting held June 20, 2023. Burzik previously served as the Company’s Chair of the Board from 2021-2022 before assuming the position of Lead Independent Director of the new combined board that was formed following the merger of SeaSpine and Orthofix. Prior to joining the Orthofix Board of Directors, Burzik served as President and Chief Executive Officer of Kinetic Concepts Inc. from 2006 until the company’s sale in 2011.

Prior to that, she served as President of Applied Biosystems Group and held senior executive positions at Eastman Kodak Health Imaging Systems and President of Ortho-Clinical Diagnostics Inc., a Johnson & Johnson company. Burris served as the Senior Vice President and Chief Financial Officer (CFO) at Roche Diagnostics Corporation from 1996 through his retirement in July 2019. A member of the Global Roche Diagnostics Finance Executive Committee, Burris was recognized as one of their top senior leaders.